Last reviewed · How we verify
Preservative Free eye drop
Preservative-free eye drops provide lubrication and moisture to the ocular surface without chemical preservatives that may cause irritation.
Preservative-free eye drops provide lubrication and moisture to the ocular surface without chemical preservatives that may cause irritation. Used for Dry eye disease, Ocular surface irritation and lubrication.
At a glance
| Generic name | Preservative Free eye drop |
|---|---|
| Sponsor | Southern College of Optometry |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | FDA-approved |
Mechanism of action
These drops deliver artificial tears or active pharmaceutical ingredients in a formulation free of antimicrobial preservatives, reducing the risk of preservative-induced ocular toxicity and irritation. They are typically dispensed in single-dose units or preservative-free multi-dose containers to maintain sterility without chemical additives. This formulation is particularly beneficial for patients with sensitive eyes or those requiring frequent instillation.
Approved indications
- Dry eye disease
- Ocular surface irritation and lubrication
Common side effects
- Mild ocular irritation
- Transient blurred vision
- Foreign body sensation
Key clinical trials
- SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease (PHASE4)
- A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease (PHASE3)
- The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia (PHASE4)
- AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension (PHASE1, PHASE2)
- A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes (PHASE3)
- Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction (PHASE4)
- Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST) (NA)
- Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |